Clearance Summary
ASPIVIX v1.1 Cervical Suction Tenaculum received FDA 510(k) clearance under submission number K203820, sponsored by Aspivix SA. The device was reviewed via the Traditional premarket notification pathway and assigned to the Obstetrics/Gynecology review panel. The statutory decision date of record is 2021-08-17.
- Submission: K203820
- Applicant / Sponsor: Aspivix SA
- Clearance pathway: Traditional
- Review panel: Obstetrics/Gynecology
- Device class: Class II
- Regulation citation: 21 CFR 884.4530
- Decision date: 2021-08-17
Classification & Regulation
This clearance is catalogued under FDA product code HDC and 21 CFR 884.4530, within the Obstetrics/Gynecology review panel as a Class II device.